Shear Wave Velocity to Evaluate the Effect of Botulinum Toxin on Post-Stroke Spasticity of the Lower Limb.
botulinum toxin type A
gastrocnemius medialis muscle
post-stroke spasticity
shear wave velocity
ultrasound elastography
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
26 12 2022
26 12 2022
Historique:
received:
22
10
2022
revised:
11
12
2022
accepted:
21
12
2022
entrez:
20
1
2023
pubmed:
21
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
(1) Background: The evaluation of muscles with spasticity using ultrasound elastography has attracted attention recently, and the shear wave velocity (SWV) technique can measure the mechanical properties of tissues objectively and quantitatively. The purpose of this study was to evaluate the effect of using SWV to assess the effect of Botulinum toxin type A (BoNT-A) treatment in adult patients with post-stroke lower limb spasticity. (2) Methods: We assessed the modified Ashworth Scale, the modified Tardieu Scale, and SWV at rest and after stretching before and at 1 month after BoNT-A treatment in 10 adult participants with post-stroke lower limb spasticity. (3) Results: Significant changes in SWV of the ankle joint in maximum dorsiflexion to the extent possible (SWV stretched) were observed after BoNT-A treatment. SWV stretched was positively correlated with joint range of motion. Participants whose joint range of motion did not improve (i.e., gastrocnemius medialis muscle (GCM) extension distance did not change) had significantly more reductions in SWV stretched after BoNT-A treatment. (4) Conclusions: Our results suggest that the SWV measurements may serve as a quantitative assessment to determine the effect of the BoNT-A treatment in adult stroke patients. SWV measurements to assess GCM spasticity should consider the effects of tension, material properties and activation level of muscles. The challenge is to measure SWV with matching limb positions in patients without contractures.
Identifiants
pubmed: 36668834
pii: toxins15010014
doi: 10.3390/toxins15010014
pmc: PMC9865964
pii:
doi:
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Neuromuscular Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Noro Psikiyatr Ars. 2018;55(Suppl 1):S49-S53
pubmed: 30692856
J Biomech. 2019 Aug 27;93:232
pubmed: 31285048
Muscle Nerve Suppl. 1997;6:S1-13
pubmed: 9826979
Toxins (Basel). 2020 Dec 14;12(12):
pubmed: 33327423
Top Stroke Rehabil. 2017 Jan;24(1):12-17
pubmed: 27211845
Dev Med Child Neurol. 2016 Dec;58(12):1288-1294
pubmed: 27374483
Neurol Neurochir Pol. 2010 Jul-Aug;44(4):404-11
pubmed: 20827614
J Biomech. 2015 Sep 18;48(12):3539-42
pubmed: 26113291
Physiol Meas. 2013 Jun;34(6):713-21
pubmed: 23719230
Physiol Meas. 2018 Nov 06;39(11):115003
pubmed: 30398162
Phys Ther. 1987 Feb;67(2):206-7
pubmed: 3809245
Ultrasound Med Biol. 2017 Jun;43(6):1105-1111
pubmed: 28285729
Clin Neurophysiol Pract. 2021 Jun 16;6:194-202
pubmed: 34278056
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):265-9
pubmed: 8795597
Mov Disord. 2009 Jul 30;24(10):1494-503
pubmed: 19489066
Stroke. 2004 Jan;35(1):134-9
pubmed: 14684785
Clin Rehabil. 2005 Oct;19(7):751-9
pubmed: 16250194
Brain Inj. 2008 Dec;22(13-14):1007-12
pubmed: 19117179
Muscle Nerve Suppl. 1997;6:S146-68
pubmed: 9826987
Front Neurol. 2022 Oct 10;13:980746
pubmed: 36299267
Front Neurol. 2021 Apr 16;12:630435
pubmed: 33935939
J Ultrasound. 2018 Sep;21(3):241-247
pubmed: 30030747
Eur J Neurol. 2006 Dec;13 Suppl 4:35-40
pubmed: 17112348
Spinal Cord. 2017 Oct;55(10):944-949
pubmed: 28485384
Arch Phys Med Rehabil. 2014 Aug;95(8):1564-70
pubmed: 24792138
Mov Disord. 2009 Apr 30;24(6):801-12
pubmed: 19224614
Ultrasound Med Biol. 2019 May;45(5):1094-1102
pubmed: 30898386
J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2416-22
pubmed: 26232889
Phys Ther. 1966 Apr;46(4):357-75
pubmed: 5907254
Sci Rep. 2021 Feb 11;11(1):3577
pubmed: 33574381
Clin Rehabil. 2002 Aug;16(5):515-22
pubmed: 12194622
Arch Phys Med Rehabil. 2012 Nov;93(11):2085-9
pubmed: 22776155
Clin Biomech (Bristol, Avon). 2015 Mar;30(3):269-75
pubmed: 25638688
J Med Ultrason (2001). 2020 Oct;47(4):609-615
pubmed: 32705628
Neurology. 2004 Nov 23;63(10):1971-3
pubmed: 15557529
Muscle Nerve. 2018 Feb;57(2):222-228
pubmed: 28561920
Arch Phys Med Rehabil. 2014 Nov;95(11):2207-19
pubmed: 25064780
Skeletal Radiol. 2018 Apr;47(4):457-471
pubmed: 29224123
Am J Phys Med Rehabil. 2016 Dec;95(12):899-910
pubmed: 27149584
J Neuroeng Rehabil. 2022 Feb 5;19(1):15
pubmed: 35120556
Clin Biomech (Bristol, Avon). 2017 Nov;49:48-55
pubmed: 28866442
J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):46-52
pubmed: 19770162
Arch Phys Med Rehabil. 2012 Jul;93(7):1253-8
pubmed: 22502807
Dev Med Child Neurol. 2000 Jan;42(1):32-41
pubmed: 10665973
J Neural Transm (Vienna). 2008;115(4):617-23
pubmed: 18322637
Ultrasound Med Biol. 2018 Sep;44(9):1931-1940
pubmed: 29398131
Arch Rehabil Res Clin Transl. 2020 Jul 01;2(4):100071
pubmed: 33543098
Toxins (Basel). 2019 Dec 05;11(12):
pubmed: 31817426
Am J Phys Med Rehabil. 2018 Jul;97(7):500-506
pubmed: 29406405
Brain Inj. 2010;24(11):1372-8
pubmed: 20715900
J Med Ultrason (2001). 2018 Apr;45(2):295-300
pubmed: 28900767